Hatem Soliman

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Living with Metastatic Cancer: A Roadmap for Future Research”.

Living with Metastatic Cancer: A Roadmap for Future Research

Cancers(2020)10.3390/cancers12123684

N/A

1.9DataRank · unranked

48 citations

Kelly A. Hyland, Hatem Soliman, Heather Jim, Laura B. Oswald, Danielle B. Tometich

Preliminary efficacy data of triple-negative breast cancer cohort of NCI 9881 study: A phase II study of cediranib in combination with olaparib in advanced solid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1077

N/A

0.312DataRank · unranked

7 citations

Hatem Soliman, Siqing Fu, Karen A. Gelmon, Albiruni Ryan Abdul Razak, Pamela N. Münster +11 more

Preliminary efficacy data of platinum-pretreated small cell lung cancer (SCLC) cohort of NCI 9881 study: A phase II study of cediranib in combination with olaparib in advanced solid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9065

N/A

0DataRank · unranked

10 citations

Navid Hafez, Hatem Soliman, Siqing Fu, Shumei Kato, Primo N. Lara +12 more

The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake

Immunity(2021)10.1016/j.immuni.2021.04.019

N/A

0DataRank · unranked

250 citations

Kay Hänggi, Daiana P. Celias, Alycia Gardner, Jie Li, Bruna M. Batista Bittencourt +14 more

Analysis of homologous recombination DNA repair gene mutation status in patients with metastatic small cell lung cancer treated with cediranib and olaparib on NCI 9881 study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8563

N/A

0DataRank · unranked

0 citations

Marc R. Radke, Navid Hafez, Hatem Soliman, Siqing Fu, Shumei Kato +11 more

A mixed-methods study characterizing experiences of medical oncologists’ use of gonadotropin-releasing hormone agonists for treatment of breast cancer

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07734-2

N/A

0DataRank · unranked

1 citations

Bo Hu, Dinorah Martinez Tyson, Carley Geiss, Susan T. Vadaparampil, Heather Jim +5 more

Design of a cluster randomized multi-level intervention to decrease barriers to minority cancer patient referral and enrollment to cancer clinical trials: The ACT WONDER2S study

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.108096

N/A

0DataRank · unranked

1 citations

Melany Garcia, Rossybelle P. Amorrortu, Yayi Zhao, Brian S. Mittman, Kea Turner +13 more

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Annals of Surgical Oncology(2020)10.1245/s10434-019-08039-7

N/A

0DataRank · unranked

26 citations

Susanne Wagner, Darl D. Flake, Mark E. Robson, Lee S. Schwartzberg, Priyanka Sharma +7 more